Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 33473

Case report
Table of Contents - Year : 2017 | Month : April | Volume : 11 | Issue : 4 | Page : XD01 - XD03

Extramedullary Solitary Plasmacytoma: Demonstrating the Role of 18F-FDG PET Imaging XD01-XD03

Archana Gautam, Kamal Kant Sahu, Ahsan Alamgir, Imran Siddiqi, Sikander Ailawadhi

Correspondence
Dr. Sikander Ailawadhi,
Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, USA 32224.
E-mail: ailawadhi.sikander@mayo.edu

An Extramedullary Plasmacytoma (EMP) is characterized by a neoplastic proliferation of clonal plasma cells outside the medullary cavity. EMPs are a rare occurrence compared to other malignant plasma cell disorders and account for approximately 3-5% of plasma-cell neoplasms. Although most cases of EMP are not immediately life threatening at diagnosis, EMPs can progress to Multiple Myeloma (MM) and thus, warrant monitoring. Currently, there are no standard guidelines for when and how to monitor patients who are diagnosed with or treated for a solitary plasmacytoma. We present a case of solitary EMP who was treated adequately and definitively but developed a distinct, non-contiguous subsequent solitary EMP and was only discovered due to surveillance 18F-Fludeoxyglucose Positron Emission Tomography (18F-FDG) (PET) scan. Uniform surveillance guidelines should be developed and the potential benefits of PET and other imaging techniques as well as their cost should be considered.